Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Mycophenolate mofetil for transplantation: new drug, old problems?

Gray DW.

Lancet. 1995 Aug 12;346(8972):390. No abstract available.

PMID:
7623565
2.

Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?

Byrne R, Yost SE, Kaplan B.

Clin Pharmacol Ther. 2011 Aug;90(2):204-6. doi: 10.1038/clpt.2011.95. No abstract available.

PMID:
21772295
3.

[Mycophenolate mofetil, a possible new immunosuppresant].

Weberová J, Voboril R, Semecký V.

Ceska Slov Farm. 2002 Sep;51(5):220-5. Review. Czech.

PMID:
12407919
4.

Immunosuppressive activity of mycophenolate mofetil.

Eugui EM, Allison AC.

Ann N Y Acad Sci. 1993 Jun 23;685:309-29. Review. No abstract available.

PMID:
8363235
5.

Mycophenolate mofetil--a new immunosuppressant for organ transplantation.

[No authors listed]

Med Lett Drugs Ther. 1995 Sep 29;37(958):84-6. No abstract available.

PMID:
7674993
6.

[Mycophenolate mofetil: a new approach by immunosuppressive treatment].

Thervet E.

Pathol Biol (Paris). 2001 Feb;49(1):9-11. French. No abstract available.

PMID:
11265229
7.

Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.

Smak Gregoor PJ, van Gelder T, Weimar W.

Neth J Med. 2000 Dec;57(6):233-46. Review.

PMID:
11099793
8.

Mycophenolate mofetil for the transplanted kidney?

[No authors listed]

Drug Ther Bull. 1997 May;35(5):38-40. Review.

PMID:
9282420
9.

The design and development of an immunosuppressive drug, mycophenolate mofetil.

Allison AC, Eugui EM.

Springer Semin Immunopathol. 1993;14(4):353-80. Review. No abstract available.

PMID:
8322167
10.

Mycophenolate mofetil.

Lipsky JJ.

Lancet. 1996 Nov 16;348(9038):1357-9. Review. No abstract available.

PMID:
8918281
11.

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

Allison AC, Eugui EM.

Clin Transplant. 1996 Feb;10(1 Pt 2):77-84. Review.

PMID:
8680053
12.

Mycophenolate mofetil in cardiac transplantation.

Kobashigawa JA.

Curr Opin Cardiol. 1998 Mar;13(2):117-21.

PMID:
9593551
13.

Mycophenolate mofetil: a unique immunosuppressive agent.

Hood KA, Zarembski DG.

Am J Health Syst Pharm. 1997 Feb 1;54(3):285-94. Review.

PMID:
9028422
14.

Effects of mycophenolate mofetil on hematocrit after renal transplantation.

Chenhsu RY, Wu YM, Min DI, Zimmerman MB.

Ann Pharmacother. 2002 Sep;36(9):1479-80. No abstract available.

PMID:
12196073
15.

Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.

Davin JC, Gruppen M, Bouts AH, Groothoff JW, van Amstel SP, Surachno J, ten Berge IJ, Weening JJ.

Nephrol Dial Transplant. 1999 Apr;14(4):984-7. No abstract available.

PMID:
10328487
16.

Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.

Bestetti RB, Souza TR, Lima MF, Theodoropoulos TA, Cordeiro JA, Burdmann EA.

Transplantation. 2007 Aug 15;84(3):441-2. No abstract available.

PMID:
17700175
17.

Mycophenolate mofetil in kidney transplantation.

Lui SL, Halloran PF.

Curr Opin Nephrol Hypertens. 1996 Nov;5(6):508-13. Review.

PMID:
8978998
18.

Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.

McKane W, Kanganas C, Preston R, Cairns T, Hakim N, Palmer A, Taube D.

Transplant Proc. 2001 Feb-Mar;33(1-2):1224-5. No abstract available.

PMID:
11267268
19.

[Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].

Sánchez-Fructuoso AI.

Nefrologia. 2005;25(3):234-42, 244. Spanish. No abstract available.

20.

Supplemental Content

Support Center